National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-01

Study Completion Date

2018-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study involves the evaluation of a decision support tool, based on the patient version of the NCCN guidelines, for the non-small cell lung cancer patient population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention

NCT02962115

Lung Neoplasms

COMPLETED NA

Lung Cancer Informational Study (LCIS)

NCT00579215

Cancer Enhanced Care Decision-Making +3 more

COMPLETED NA

Lung Cancer Information Study (LCIS-R01)

NCT01924416

Non-Small-Cell Lung Cancer

COMPLETED NA

Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer

NCT05416983

Lung Non-Small Cell Carcinoma

COMPLETED

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

NCT05292521

Lung Non-Small Cell Carcinoma Stage I Lung Cancer AJCC v8 Stage IA1 Lung Cancer AJCC v8 +6 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study involves the evaluation of a decision support tool, based on the patient version of the NCCN guidelines, for the non-small cell lung cancer patient population. The decision support tool is offered by a trained coordinator to the patient and then utilized during an initial consultation. Patients complete forms before and after the visit indicating their level of decisional conflict, satisfaction, and satisfaction with decision. Pre-determined indices of quality of care were also collected by the study team.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Decision support tool

Participants receive training in use of a decision support tool by a trained coordinator.

Group Type EXPERIMENTAL

Decision support tool

Intervention Type BEHAVIORAL

Internet-Based, interactive decision support tool

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Decision support tool

Internet-Based, interactive decision support tool

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over age of 18
* Able to provide informed consent
* Able to use a web-based interface
* Histologically proven or clinically apparent diagnosis of non-small cell lung cancer
* Newly diagnosed, with new primary occurrence of NSCLC, or diagnosed with a new recurrence or new progression of existing disease, and not yet treated for the new problem
* Being seen in consultation at thoracic oncology clinics

Exclusion Criteria

* Unable to fill out questionnaires
* Already treated for the current diagnosis of a new primary occurrence of NSCLC, or already treated for the new recurrence or new progression of existing disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No